How does pharmaceutical sector respond to the challenges posed by the environmental impact of medicines? What issues need to be considered at different stages of a medicine's life cycle? How are environmental impacts and mitigation measured? What solutions are available now and in the future?
The Nordic medicines Sustainability Forum 2021 brings together all Nordic players in the pharmaceutical industry to discuss current environmental impacts. The program of the event covers stages of the drug life cycle, from manufacturing to patient and drug disposal. Speakers are leading experts in the field from Nordic countries. You will learn about measuring the environmental impact of medicines and hear practical case examples of implementing environmental projects as part of your company's day-to-day operations.
Target groups
For all pharmaceutical and healthcare actors, hospital pharmacies and their stakeholders affected by environmental responsibility:
- Quality and regulatory affairs
- Market access, pricing and reimbursement, tenders
- Product managers
- Sustainability managers and specialists
- Distribution and manufacturing
- Sales and marketing
- Universities
- Authorities
- Specialists interested in medicines sustainability and environmental issues
In this training you will learn
- How to take into account the environmental impact of a medicine at different stages of its life cycle
- How to measure the environmental impact of a medicine and how to reduce impacts, challenges of measuring impacts
- How you can take into account the reduction of the environmental impact of medicines in your own business
- Concrete case examples of solutions that are useful in your own work
Program
(Times UTC +02.00)
9.00 Webinar platform opens
9.30 Welcome and introduction
Moderator: Katja Tolkki, Head of Sustainability, Oriola
Ulla Partanen, Head of Learning Services, Lääketietokeskus
MORNING AGENDA - HOW TO MEASURE GREENNESS?
9.35 From manufacturing to patient - sustainability and environment aspect of medicines
Bengt Mattson, Policy Manager, LIF
Path from manufacturing to patient is long and includes different steps. Where to pay attention to in terms on sustainability and environment issues? What is trending now/in the future and what was trending before? What is currently happening in EU level and in the Nordics?
10.10 Introduction to case examples: Which criteria to use for greenness?
Introduction to topic: Sanja Karlsson, SUDDEN Project Coordinator, University of Helsinki
Defining the criteria to use for greenness is not an easy task. What kind of criteria is used, might be used and what kind of evaluation has been around different possibilities?
10.30 Case example of implementation: Tendering in Norwegian hospital districts
Laila Pagh-Skov, Quality Manager, Sykehusinnkjøp HF
10.50 Case example of implementation: Medicines Environmental classification, Välvald
Lisa Stern Ödmark, Chefsstrateg, Sveriges Apoteksförening
11.10 Break
11.30 Case example of implementation: Pharma Company Environmental targets, KPIs and actions
Deb Mangone, CEO, Pfizer Finland
11.50 Finnish and Swedish pharmaceutical environmental classifications
Lisette Graae, Miljötillstånd och åtgärdsstrategier, IVL Svenska Miljöinstitutet
Elli Leppä, Development Pharmacist, Pharmaceutical Information Centre
By listening this dual presentation you will learn about the pharmaceutical environmental classification systems in Sweden and Finland. Sweden has established the classification in 2005 and Finland is soon introducing the classification for healthcare professionals. What kind of learnings and solutions are done? Listen and find it out!
12.30 Lunch break & networking
13.30 AFTERNOON AGENDA - TRANSPARENCY IN PRODUCTION CHAIN
13.40 Using Circular economy as a driver for zero environmental impact
Dorethe Nielsen, Vice President, Circular for Zero, Corporate Environmental Strategy, Novo Nordisk A/S
14.40 Break
15.00 What are the current topics that pharmaceutical companies work with in terms of environment and human rights?
Kati Nyman, Head of Communications, Public Affairs, Science and Sustainability in Bayer Nordic Region
15.20 PANEL DISCUSSION - what we can learn from each other
Moderator: Katja Tolkki, Head of Sustainability, Oriola
Discussing with Katja: Dorethe Nielsen, Kati Nyman and Bengt Mattson
16.15 Summary and end of the day
Moderator: Katja Tolkki, Head of Sustainability, Oriola
Ulla Partanen, Head of Learning Services, Lääketietokesku
About the training
The training takes place in 24th of November 2021 and is arranged as a live webinar.
Attend the live webinar or watch the recording later. In the live webinar you will be able to ask the speakers questions via the chat. You will also receive a recording of the webinar, which will be available for one month. Changes in the program are possible.
Program has been planned together with program committee:
• Bengt Mattson, Policy Manager, LIF
• Elli Leppä, Development Pharmacist, Lääketietokeskus
• Sanja Karlsson, Project Coordinator, Sudden Project/University of Helsinki
• Joonas Laine, One-Pfizer Tender Lead, Hospital Business Unit, Pfizer
• Katja Tolkki, Head of Sustainability, Oriola
This event has received funding from the Nordic Life Science Learning project of the Nordplus Horizontal program.
·
Registration
Price of the webinar is 495 € (+ VAT).
You can register using the registration form on this web page. For group orders, please contact us: koulutus@laaketietokeskus.fi.
Please read the changes and cancellations policy before registering to the event on the website at: Instructions for participants.